This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Innovations by Xin Xia in Pharmaceutical Delivery Systems
Introduction
Xin Xia is an innovative inventor based in Southeast Asia, known for his contributions to the field of pharmaceutical delivery systems. His work focuses on the development of advanced materials that enhance the delivery of bioactive compounds to specific areas of the body.
Latest Patents
Xin Xia holds a notable patent titled "A Process For Manufacturing Porous Silica Particles Loaded With At Least One Bioactive Compound Adapted For Lung, Nasal, Sublingual And/or Pharyngeal Delivery." This invention relates to a process for manufacturing porous silica particles that contain at least one bioactive compound. The particles are specifically designed for effective delivery to the lung, nasal passages, sublingual area, and pharynx. The particles have a mass median aerodynamic diameter (MMAD) ranging from 0.5 to 15 µm, with a geometric standard deviation (GSD) of less than 2.5. Additionally, the invention encompasses a pharmaceutical composition that includes these silica particles and their application in diagnosing, preventing, and treating local and systemic disorders, particularly those affecting the lung, nose, sublingual area, and pharynx.
Career Highlights
Xin Xia is currently employed at Nanologica AB, a company that specializes in innovative silica-based solutions for pharmaceutical applications. His work at Nanologica AB has positioned him as a key player in the development of advanced drug delivery systems.
Collaborations
Xin collaborates with Chunfang Zhou, a talented woman in the field, contributing to the advancement of their shared research goals.
Conclusion
Xin Xia's innovative work in the field of pharmaceutical delivery systems demonstrates his commitment to improving healthcare through advanced technology. His contributions are paving the way for more effective treatments for various disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile